Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

NCT01423890 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.

NCT NCT01423890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01423890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
Lead sponsor
Ontario Clinical Oncology Group (OCOG)
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
February 28, 2014
Enrollment
1,011 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer